Medical Research
(H30Z)
IRS Verified
DX Registered
990 on File
PAPANICOLAOU CORPS FOR CANCER RESEARCH INC
Financial strength (30%)
37/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$5.0M
Total Revenue
$2.2M
Total Expenses
$-9,426,640
Net Assets
7
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
49.0%
Fundraising Efficiency
34.3%
Operating Reserve
-51.07x
Liability-to-Asset
302.1%
Revenue Diversification
92.7%
Executive Compensation
$249K
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
49.0% | 83.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
23.5% | 9.9% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
27.6% | 2.6% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
34.3% | 110.6% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
-51.1 mo | 14.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
302.1% | 13.2% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
92.7% | 90.0% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
0.4% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-58.5% | 3.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
56.0% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $5.0M | $2.2M | $-9,426,640 | 49.0% | 7 |
| 2024 | $5.0M | $5.3M | $-18,864,211 | 77.7% | 7 |
| 2023 | $10.0M | $9.9M | $-18,600,677 | 87.4% | 12 |
| 2022 | $4.1M | $2.0M | $-18,705,097 | 48.1% | 16 |
| 2021 | $2.8M | $1.7M | N/A | — | 13 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.